Endoscopy Market Size, Growth, Share and Forecast 2032

Endoscopy market size was valued at USD 29,490.5 million in 2024 and is projected to reach USD 40,359.7 million by 2032.

By End-User (Hospitals, Ambulatory surgical centers); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); By Application (Arthroscopy, ENT endoscopy, Pulmonary endoscopy, Obstetrics/Gynecology); By Product Type (Endoscopes, Visualization systems, Endoscopic ultrasound, Insufflator)

SKU: CR16436Report Pages: 250Category: Medical DevicesReport Format: PDF, ExcelLast Updated: Aug 12Author: Dr. Pankaj SharmaReviewed by: Deepti AgrawalPreferred on

Market Report Metrics

Revenue, 2024 -
USD 29,490.5 million
Forecast Year -
2032
CAGR (2024–2032)
4%
Report Coverage
Global

Market Overview

The Endoscopy Market size was valued at USD 29,490.5 million in 2024 and is anticipated to reach USD 40,359.7 million by 2032, growing at a CAGR of 4% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2024
Base Year 2024
Forecast Period 2025-2032
Endoscopy Market Size 2024 USD 29,490.5 Million
Endoscopy Market, CAGR 4%
Endoscopy Market Size 2032 USD 40,359.7 Million
 

The Endoscopy market experiences strong growth driven by technological advancements such as high-definition imaging and disposable endoscopes that improve diagnostic accuracy and patient safety. Rising prevalence of chronic diseases and an expanding geriatric population increase demand for minimally invasive diagnostic and therapeutic procedures. Growing awareness of preventive healthcare and government initiatives promoting early disease detection further boost market adoption. Trends include rapid integration of artificial intelligence to enhance real-time diagnostics and the expansion of telemedicine platforms, which extend specialist access to remote areas. Together, these factors accelerate innovation and broaden the market’s clinical applications worldwide.

The Endoscopy market demonstrates strong presence across North America, Europe, and Asia-Pacific, driven by advanced healthcare infrastructure and growing demand for minimally invasive procedures. North America leads with significant adoption of cutting-edge technologies, while Asia-Pacific shows rapid growth due to improving healthcare access and increasing chronic disease prevalence. Key players shaping the market include Olympus, KARL STORZ, Johnson & Johnson, and Boston Scientific.

Market Insights

  • The Endoscopy market was valued at USD 29,490.5 million in 2024 and is projected to reach USD 40,359.7 million by 2032, growing at a CAGR of 4% during the forecast period.
  • Technological advancements such as high-definition imaging and disposable endoscopes drive market growth by improving diagnostic accuracy and patient safety.
  • Increasing prevalence of chronic diseases and expanding geriatric populations fuel demand for minimally invasive diagnostic and therapeutic procedures.
  • Integration of artificial intelligence and telemedicine platforms enhances real-time diagnostics and expands access to specialized care in remote regions.
  • The market faces challenges from high equipment costs and strict regulatory requirements, which slow adoption in price-sensitive and developing markets.
  • North America and Europe dominate due to advanced healthcare infrastructure and favorable reimbursement policies, while Asia-Pacific shows rapid growth with improving healthcare facilities.
  • Major players like Olympus, KARL STORZ, Johnson & Johnson, and Boston Scientific invest heavily in R&D to introduce innovative products and strengthen their global market position.

Endoscopy Market Size and Segmentation

Market Drivers

Key Factors Driving Growth in the Endoscopy Market Include Technological Advancements and Rising Prevalence of Chronic Diseases

Technological advancements in endoscopic equipment have significantly propelled market growth. Innovations such as high-definition imaging, flexible endoscopes, and disposable devices improve diagnostic accuracy and patient safety. These enhancements facilitate minimally invasive procedures, reducing recovery time and hospital stays. Increasing prevalence of chronic diseases like gastrointestinal disorders, cancer, and respiratory conditions creates a strong demand for early diagnosis and treatment through endoscopy. Hospitals and diagnostic centers prioritize investment in advanced endoscopic tools to meet clinical needs and improve patient outcomes.

  • For instance, Medtronic’s AI-enabled endoscopy platform processes over 2000 images per procedure, assisting clinicians in identifying subtle mucosal changes and reducing miss rates during colorectal cancer screenings.

Expanding Geriatric Population and Growing Awareness of Preventive Healthcare Boost Market Demand

The growing geriatric population worldwide drives demand for endoscopic procedures since older adults face higher risks of conditions that require minimally invasive diagnosis. Increased health awareness among patients and healthcare providers encourages regular screenings and early interventions. Governments and private organizations promote preventive healthcare programs that include endoscopic examinations for cancer screening and other chronic diseases. The rising acceptance of outpatient procedures due to shorter recovery times and cost efficiency also contributes to greater utilization of endoscopy services.

  • For instance, Olympus launched its EVIS X1 endoscopy system featuring enhanced image processing at 60 frames per second, improving lesion detection and enabling real-time diagnostics.

Rising Investments in Healthcare Infrastructure and Favourable Reimbursement Policies Stimulate Market Expansion

Many countries have increased healthcare spending and expanded infrastructure, leading to enhanced availability of endoscopic services. Improved access to modern medical facilities allows more patients to benefit from endoscopic diagnostics and treatments. Insurance providers and government bodies offer favourable reimbursement policies that reduce out-of-pocket expenses for patients. This financial support encourages healthcare providers to adopt advanced endoscopic technologies and increase procedure volumes. It also helps in overcoming cost barriers that previously limited widespread adoption of endoscopy.

Increasing Integration of Artificial Intelligence and Digital Technologies in Endoscopic Procedures

The integration of artificial intelligence (AI) and digital technologies enhances the capabilities of endoscopy systems. AI-powered image analysis aids clinicians in detecting abnormalities with higher precision and speed. Digital documentation and telemedicine platforms improve data management and remote consultation opportunities. These advancements improve diagnostic confidence and streamline workflow efficiency in healthcare settings. The market benefits from continuous innovation that supports better clinical decision-making and patient care through endoscopic methods.

Rapid Adoption of Minimally Invasive Procedures and Patient-Centric Technologies in the Endoscopy Market

The growing preference for minimally invasive procedures drives significant trends within the endoscopy market. These procedures reduce patient discomfort and shorten recovery periods, leading to higher acceptance rates among both patients and healthcare providers. Endoscopic technologies continue to evolve with enhanced imaging capabilities and improved maneuverability, enabling more precise diagnostics and interventions. Healthcare facilities focus on integrating patient-centric devices that ensure safety and improve clinical outcomes. The shift toward outpatient care settings also fuels demand for portable and user-friendly endoscopic equipment. It reflects broader efforts to optimize healthcare delivery and reduce overall treatment costs.

  • For instance, Ambu’s single-use bronchoscope models have been utilized in over 1 million procedures, demonstrating significant adoption due to their ease of use and infection control benefits.

Expansion of Disposable and Single-Use Endoscopes to Address Infection Control Challenges

Infection control remains a critical concern in healthcare, influencing endoscopy market trends toward disposable and single-use devices. These devices reduce cross-contamination risks, enhance procedural safety, and minimize the need for complex sterilization processes. Hospitals increasingly adopt single-use endoscopes to comply with stringent hygiene protocols and reduce hospital-acquired infections. Manufacturers invest in developing cost-effective disposable solutions without compromising device performance. It also supports faster procedure turnover and operational efficiency in high-volume clinical settings. The growing regulatory focus on patient safety accelerates acceptance of these disposable technologies worldwide.

  • For instance, Karl Storz offers a telemedicine platform that supports real-time video streaming and remote procedure assistance, connecting over 500 healthcare facilities worldwide.

Integration of Advanced Imaging Technologies and Artificial Intelligence for Enhanced Diagnostic Accuracy

Advanced imaging technologies such as high-definition cameras, narrow-band imaging, and 3D visualization gain traction in the endoscopy market. These tools improve lesion detection, characterization, and treatment planning. Artificial intelligence integration further refines diagnostic precision by assisting in real-time anomaly recognition and risk assessment. Such innovations reduce human error and enhance clinical decision-making during endoscopic procedures. Hospitals and clinics prioritize investments in these technologies to improve patient outcomes and streamline workflows. It marks a transition toward smarter, data-driven healthcare practices in endoscopy.

Growing Adoption of Telemedicine and Remote Consultation Platforms to Expand Access to Endoscopic Services

Telemedicine and remote consultation platforms increasingly complement traditional endoscopic services. These digital tools enable specialists to provide real-time guidance and second opinions during procedures, improving diagnostic accuracy. Remote access facilitates care delivery in underserved or rural areas where specialist availability remains limited. It supports collaborative healthcare models and enhances patient management across different locations. The endoscopy market benefits from these advancements by expanding its reach and optimizing resource utilization. Continued digital transformation within healthcare systems drives further integration of tele-endoscopy solutions.

Market Challenges Analysis

High Costs and Complex Regulatory Requirements Limit Growth Potential in the Endoscopy Market

The high costs associated with advanced endoscopic equipment and procedures present a significant challenge to market expansion. Healthcare providers in developing regions often face budget constraints that restrict acquisition of cutting-edge devices. The complexity of manufacturing and maintaining sophisticated endoscopy systems adds to overall expenses. Strict regulatory requirements and lengthy approval processes further delay product launches and increase compliance costs for manufacturers. These factors create barriers to entry for smaller companies and slow adoption rates in price-sensitive markets. It forces providers to balance cost efficiency with the need for high-quality diagnostic tools. Overcoming these financial and regulatory hurdles remains critical for sustained market growth.

Shortage of Skilled Professionals and Limited Awareness Impact Adoption of Endoscopic Procedures

The shortage of trained endoscopy specialists limits the availability and accessibility of these procedures in many regions. Training programs require time and resources, and insufficient skilled personnel restrict the volume of endoscopic diagnostics and treatments. Limited awareness about the benefits of early detection through endoscopy affects patient demand and screening rates. Healthcare facilities may hesitate to invest heavily in endoscopic technologies without a skilled workforce to operate them efficiently. It also challenges efforts to integrate advanced procedures into routine clinical practice. Bridging the gap in education and raising awareness about endoscopic applications are essential to unlock the full potential of the market.

Market Opportunities

Expanding Demand for Early Disease Detection and Minimally Invasive Treatment Options Offers Significant Opportunities in the Endoscopy Market

The growing emphasis on early diagnosis of chronic diseases creates substantial opportunities for the endoscopy market. Increasing incidence of gastrointestinal disorders, cancer, and respiratory illnesses drives demand for reliable and less invasive diagnostic tools. Healthcare providers focus on integrating endoscopic procedures to enable timely interventions and improve patient outcomes. Rising patient preference for minimally invasive treatments with shorter recovery times supports broader adoption of endoscopy technologies. It encourages manufacturers to innovate devices that enhance procedural efficiency and patient comfort. Expansion of screening programs and preventive healthcare initiatives further boosts market potential worldwide.

Emerging Markets and Technological Innovations Provide New Avenues for Market Expansion

Emerging economies present a promising landscape for endoscopy market growth due to improving healthcare infrastructure and rising healthcare expenditure. Increased government initiatives to enhance medical facilities and accessibility create favorable conditions for endoscopy adoption. Technological innovations such as artificial intelligence, disposable endoscopes, and tele-endoscopy open new frontiers in diagnostics and patient care. These advancements enable more accurate detection, reduce infection risks, and extend specialized services to remote areas. It positions the market to capitalize on unmet clinical needs and growing demand in underserved regions. Continuous investment in research and development will drive sustained expansion and competitive advantage.

Market Segmentation Analysis:

By Product Type:

Endoscopes hold a dominant position due to their essential role in performing minimally invasive diagnostic and therapeutic procedures. Visualization systems complement endoscopes by providing high-definition imaging, enabling accurate diagnosis and treatment planning. Endoscopic ultrasound devices combine endoscopy with ultrasound imaging, enhancing capabilities for detecting and staging cancers and other internal abnormalities. Insufflators play a critical role by maintaining adequate cavity inflation during procedures, ensuring better visibility and maneuverability for clinicians. Each product type addresses specific clinical needs, driving demand based on technological sophistication and procedure complexity.

  • For instance, Medtronic’s GI Genius system provides real-time lesion detection during colonoscopies by analyzing more than 50 video frames per second, significantly improving diagnostic accuracy.

By Application:

Arthroscopy leads the segment due to its widespread use in diagnosing and treating joint disorders, particularly in orthopedics and sports medicine. ENT endoscopy covers procedures related to ear, nose, and throat conditions, benefiting from advancements in flexible and high-resolution scopes. Pulmonary endoscopy supports diagnosis and intervention in respiratory diseases, an area witnessing growth due to rising respiratory illness prevalence. Obstetrics and gynecology applications include minimally invasive procedures for women's health, enhancing patient outcomes with reduced recovery times. The endoscopy market benefits from the expanding range of clinical applications that improve disease management across multiple specialties.

  • For instance, Olympus’s Narrow Band Imaging (NBI) technology enhances mucosal visualization by using specific light wavelengths, enabling detection of vascular patterns with over 90% accuracy in differentiating cancerous tissues.

By End-User:

Hospitals represent the largest segment given their comprehensive medical facilities and capacity to perform complex endoscopic procedures. Hospitals invest heavily in state-of-the-art endoscopy equipment to support a broad spectrum of diagnostic and surgical interventions. Ambulatory surgical centers (ASCs) show rapid growth due to their focus on outpatient care and cost-effective procedure delivery. ASCs increasingly adopt endoscopy technologies for procedures that do not require extended hospital stays, responding to patient preferences for convenience and shorter recovery. It highlights a shift toward decentralized healthcare delivery models, promoting broader accessibility of endoscopic services.

Segments:

Based on Product Type:

  • Endoscopes
  • Visualization systems
  • Endoscopic ultrasound
  • Insufflator

Based on Application:

  • Arthroscopy
  • ENT endoscopy
  • Pulmonary endoscopy
  • Obstetrics/Gynecology

Based on End-User:

  • Hospitals
  • Ambulatory surgical centers

Based on the Geography:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Belgium
    • Netherlands
    • Austria
    • Sweden
    • Poland
    • Denmark
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Thailand
    • Indonesia
    • Vietnam
    • Malaysia
    • Philippines
    • Taiwan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Chile
    • Colombia
    • Rest of Latin America
  • Middle East
    • UAE
    • KSA
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East
  • Africa
    • Egypt
    • Nigeria
    • Algeria
    • Morocco
    • Rest of Africa

Regional Analysis

North America

North America holds the largest share of the endoscopy market, accounting for about 38% of the global revenue. This dominance stems from the region’s advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and substantial investment in research and development. The presence of major medical device manufacturers and key market players in the U.S. and Canada further strengthens its leadership position. Increasing prevalence of chronic diseases, such as gastrointestinal and respiratory disorders, drives strong demand for diagnostic and therapeutic endoscopic procedures. Well-established reimbursement policies and growing patient awareness about minimally invasive techniques contribute to widespread utilization. Hospitals and ambulatory surgical centers in this region continuously upgrade their equipment to improve clinical outcomes and patient experiences.

Europe

Europe captures close to 28% of the global endoscopy market, making it the second-largest regional segment. The region benefits from sophisticated healthcare systems and favorable government initiatives promoting early disease detection and minimally invasive surgeries. Countries such as Germany, the UK, and France lead adoption with robust healthcare infrastructure and widespread availability of advanced endoscopic devices. Growing geriatric populations and rising incidence of chronic diseases add to the increasing demand for endoscopy procedures. European healthcare providers actively invest in high-definition imaging and disposable endoscopes to enhance patient safety and procedural efficiency. Market growth is also supported by increasing outpatient procedures performed in ambulatory surgical centers across several countries.

Asia-Pacific

The Asia-Pacific region holds an estimated 22% share in the endoscopy market, driven by improving healthcare infrastructure, rising healthcare expenditure, and expanding access to advanced medical technologies. Countries like China, India, Japan, and South Korea contribute significantly to this growth. Rising awareness about preventive healthcare and increasing prevalence of lifestyle-related diseases fuel demand for endoscopic diagnostics and treatments. The region experiences a growing number of ambulatory surgical centers, making minimally invasive procedures more accessible to a broader population. Additionally, government initiatives aimed at modernizing healthcare facilities and expanding insurance coverage create a favorable environment for market expansion. Manufacturers focus on cost-effective and innovative solutions tailored to the needs of this diverse market.

Latin America

Latin America accounts for around 7% of the global endoscopy market. The region faces challenges related to limited healthcare infrastructure and lower healthcare spending compared to developed regions. Despite this, increasing investments in healthcare modernization and growing private healthcare sectors contribute to gradual market growth. Countries like Brazil, Mexico, and Argentina lead the regional market due to expanding hospital networks and rising demand for minimally invasive diagnostic techniques. Patient awareness campaigns and government initiatives promoting early disease detection support the adoption of endoscopy technologies. There is also growing interest in portable and disposable endoscopic devices to address infection control concerns.

Middle East and Africa

The Middle East and Africa region holds approximately 5% of the global endoscopy market. Healthcare infrastructure development and increased government focus on improving medical services underpin market growth. The presence of rising chronic disease incidence and expanding private healthcare providers fuels demand for advanced diagnostic and therapeutic tools. Countries such as the UAE, Saudi Arabia, and South Africa show notable progress in adopting endoscopic technologies. Investments in training healthcare professionals and improving access to modern medical equipment further support market expansion. The market growth in this region remains gradual but shows promising potential due to ongoing healthcare reforms and rising patient demand.

Key Player Analysis

  • Johnson & Johnson
  • KARL STORZ
  • FUJIFILM
  • Smith & Nephew
  • Boston Scientific
  • Medtronic
  • RICHARD WOLF
  • B Braun
  • OLYMPUS
  • COOK MEDICAL
  • Stryker
  • INTUITIVE
  • CONMED
  • HOYA

Competitive Analysis

Key players in the Endoscopy market include Olympus, KARL STORZ, Johnson & Johnson, Boston Scientific, Medtronic, FUJIFILM, and Smith & Nephew. These companies maintain strong market positions through continuous innovation, extensive product portfolios, and global distribution networks. They invest significantly in research and development to introduce advanced technologies such as high-definition imaging systems, disposable endoscopes, and AI-integrated devices that enhance diagnostic accuracy and procedural efficiency. Strategic collaborations, mergers, and acquisitions enable these players to expand their market reach and address emerging clinical needs. They also focus on improving patient safety and minimizing procedure times, which align with healthcare providers’ goals. Competitive pricing strategies and after-sales service excellence contribute to customer retention and brand loyalty in various regions. The growing demand for minimally invasive procedures pushes these companies to develop user-friendly, portable, and cost-effective solutions. Regulatory compliance and adapting to local market requirements remain key focus areas to facilitate product approvals and market entry. As new entrants attempt to disrupt the market, established players leverage their technological expertise and strong financial resources to sustain leadership. Overall, competitive dynamics revolve around innovation, market expansion, and strategic partnerships, positioning these companies at the forefront of the evolving endoscopy market landscape.

Recent Developments

  • In January 2025, Karl Storz SE & Co. KG announced the strategic acquisition of its long-standing Swiss distributor, ANKLIN, to strengthen its direct sales presence in Switzerland.
  • In August 2024, Ambu received CE mark approval for its new-generation duodenoscopy solutions, Ambu aBox 2 and Ambu aScope Duodeno 2, for ERCP procedures.
  • In April 2024, Medtronic introduced ColonPRO™, the latest AI software for its GI Genius™ intelligent endoscopy system, aimed at improving patient care via AI integration.

Market Concentration & Characteristics

The Endoscopy market exhibits a moderately concentrated structure dominated by a few key players who control a significant portion of the global revenue. Leading companies possess strong technological expertise, extensive product portfolios, and established global distribution channels, which create high entry barriers for new entrants. It fosters intense competition focused on innovation, quality, and customer service. The market features continuous advancements in imaging technologies, disposable devices, and AI integration that differentiate players and drive competitive advantage. Healthcare providers prioritize reliable, efficient, and cost-effective solutions, influencing purchasing decisions and vendor selection. Regional variations in regulatory requirements and healthcare infrastructure also impact market dynamics and concentration. Smaller companies often specialize in niche applications or emerging technologies, contributing to market diversity but with limited scale. The balance between established multinationals and innovative smaller firms shapes the competitive landscape. It encourages collaboration, strategic partnerships, and acquisitions to expand product offerings and geographic presence. The market’s characteristic focus on technological innovation and quality performance sustains steady growth and evolving customer demands, maintaining a dynamic yet consolidated competitive environment.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Endoscopy market will continue to grow steadily driven by technological advancements.
  2. Minimally invasive procedures will gain greater adoption across medical specialties.
  3. Artificial intelligence integration will enhance diagnostic accuracy and procedural efficiency.
  4. Disposable and single-use endoscopes will see increased demand to improve infection control.
  5. Expansion of outpatient and ambulatory surgical centers will boost market growth.
  6. Emerging markets will offer significant opportunities due to improving healthcare infrastructure.
  7. Telemedicine and remote consultation will expand access to endoscopic services.
  8. Manufacturers will focus on developing portable and user-friendly devices.
  9. Increasing prevalence of chronic diseases will sustain demand for endoscopic diagnostics.
  10. Strategic partnerships and mergers will intensify competition and foster innovation.
Endoscopy Market Size, Growth, Share and Forecast 2032
Report Attribute Details
Details
Historical Period
-
Base Year
2024
Forecast Period
2024–2032
Endoscopy Size 2024
USD 29,490.5 million
Endoscopy CAGR
4%
Endoscopy Size 2032
USD 40,359.7 million

Request a Free Sample

Fill in your details and we'll send you a free sample report.

  • Sample data tables & charts
  • Research methodology

Market Dynamics

Technological Advancements in Endoscopic Equipment

Innovations such as high-definition imaging, flexible and disposable endoscopes, and AI-powered diagnostic tools are improving accuracy, patient safety, and procedural efficiency, making endoscopy more attractive for both providers and patients.

Rising Prevalence of Chronic Diseases and Aging Population

The increasing incidence of gastrointestinal, respiratory, and oncological conditions, coupled with a growing geriatric population, is driving demand for minimally invasive diagnostic and therapeutic endoscopic procedures.

Expansion of Preventive Healthcare and Early Disease Detection

Greater awareness among patients and healthcare providers, along with government initiatives promoting early screening, is boosting the adoption of endoscopy for preventive diagnostics and timely intervention.

Integration of Artificial Intelligence and Telemedicine

AI-enhanced image analysis and tele-endoscopy platforms are enabling real-time diagnostics, improving clinical decision-making, and expanding access to specialized care in remote and underserved regions.

Favorable Reimbursement Policies and Healthcare Infrastructure Investments

Supportive insurance coverage and increased spending on healthcare infrastructure, especially in developed regions, are reducing financial barriers and encouraging the adoption of advanced endoscopic technologies.

Need a Custom Version of This Report?

Tailor the scope, geography, or segments to your exact requirements.

  • Custom geography or segment scope
  • Direct access to our analyst team

Frequently Asked Questions

What is the current market size for Endoscopy market, and what is its projected size in 2032?
The Endoscopy market was valued at USD 29,490.5 million in 2024 and is expected to reach USD 40,359.7 million by 2032.
At what Compound Annual Growth Rate is the Endoscopy Market projected to grow between 2025 and 2032?
The market is projected to grow at a CAGR of 4% during this period.
Which Endoscopy market segment held the largest share in 2024?
The endoscopes segment held the largest share by product type in 2024.
What are the primary factors fueling the growth of the Endoscopy market?
Technological advancements and rising prevalence of chronic diseases primarily drive market growth.
Who are the leading companies in the Endoscopy Market?
Key players include Olympus, KARL STORZ, Johnson & Johnson, and Boston Scientific.
Which region commanded the largest share of the Endoscopy market in 2024?
North America held the largest regional share with approximately 38%.

Table of Content

Chapter 1 Market Segmentation

  • 1.1 Segmentation Framework
    • 1.1.1 Product and Service Classification
    • 1.1.2 Application and End-Use Classification
    • 1.1.3 Technology and Solution Classification
    • 1.1.4 Customer and Distribution Channel Classification
    • 1.1.5 Geographic Segmentation
    • 1.1.6 Market Segment Definitions and Boundaries
  • 1.2 By End-User
    • 1.2.1 Hospitals
    • 1.2.2 Ambulatory surgical centers
  • 1.3 By Application
    • 1.3.1 Arthroscopy
    • 1.3.2 ENT endoscopy
    • 1.3.3 Pulmonary endoscopy
    • 1.3.4 Obstetrics/Gynecology
  • 1.4 By Product Type
    • 1.4.1 Endoscopes
    • 1.4.2 Visualization systems
    • 1.4.3 Endoscopic ultrasound
    • 1.4.4 Insufflator

Chapter 2 Introduction

  • 2.1 Report Objectives and Scope
  • 2.2 Product Definition and Industry Terminology
  • 2.3 Market Inclusions and Exclusions
  • 2.4 Research Process
    • 2.4.1 Primary Research and Expert Interviews
    • 2.4.2 Secondary Research and Source Review
    • 2.4.3 Top-Down and Bottom-Up Estimation
    • 2.4.4 Data Triangulation and Verification
  • 2.5 Market Size Measurement Basis
    • 2.5.1 2024: USD 29,490.5 million → 2032: USD 40,359.7 million
  • 2.6 Historical and Forecast Reference Periods
    • 2.6.1 Base Year: 2024
    • 2.6.2 Forecast Period: 2024-2032
  • 2.7 Research Assumptions and Limitations

Chapter 3 Executive Summary

  • 3.1 Market Snapshot and Key Findings
  • 3.2 Base-Year Market Size, 2024
  • 3.3 Forecast Market Size, 2032
  • 3.4 Revenue and Volume Growth Outlook
  • 3.5 Key Demand and Supply Indicators
  • 3.6 Leading Market Segments
  • 3.7 Fastest-Growing Market Opportunities
  • 3.8 Regional Performance Highlights
  • 3.9 Technology and Industry Transformation
  • 3.10 Competitive Landscape Summary
  • 3.11 Analyst View and Strategic Implications

Chapter 4 Global Endoscopy Market Trends and Developments

  • 4.1 Historical Industry Development
  • 4.2 Recent Market Trends and Developments
  • 4.3 Demand and Customer Behavior Trends
  • 4.4 Technology and Product Innovation
  • 4.5 Artificial Intelligence, Automation and Digitalization
  • 4.6 Local Manufacturing and Supply Chain Realignment
  • 4.7 Industry Partnerships, Mergers and Acquisitions
  • 4.8 Sustainability and Circular Economy Developments
  • 4.9 Government and Private Sector Investment Trends
  • 4.10 Emerging Business Models and Commercialization
  • 4.11 Industry Developments and Announcements

Chapter 5 Global Endoscopy Market Production, Supply and Demand Analysis

  • 5.1 Demand Trend and Consumption Analysis
  • 5.2 Demand Forecast, 2024-2032
  • 5.3 Production and Output Trend
  • 5.4 Production and Output Forecast, 2024-2032
  • 5.5 Installed Capacity and Capacity Utilization
  • 5.6 Company-Wise Production Plants and Statistics
    • 5.6.1 Installed Production Capacity
    • 5.6.2 Actual Production
    • 5.6.3 Planned Capacity and Expansion Targets
  • 5.7 Supply Chain Structure and Procurement Trends
  • 5.8 Supply-Demand Gap and Bottlenecks
  • 5.9 Import Dependence and Sourcing Structure
  • 5.10 Contract Manufacturing and Outsourcing
  • 5.11 Regional Supply and Demand Concentration

Chapter 6 Global Endoscopy Market Pricing Analysis

  • 6.1 Pricing Structure and Measurement
  • 6.2 Historical Pricing Trends
  • 6.3 Pricing Outlook, 2024-2032
  • 6.4 Average Selling Price and Unit Economics
  • 6.5 Pricing by Product and Market Segment
  • 6.6 Geographic Pricing Differences
  • 6.7 Key Input, Energy, Labor and Logistics Costs
  • 6.8 Contract Pricing and Purchasing Models
  • 6.9 Pricing Sensitivity and Competitive Positioning
  • 6.10 Price, Margin and Profitability Implications

Chapter 7 Global Endoscopy Market Dynamics

  • 7.1 Market Growth Drivers
    • 7.1.1 Demand-Side Drivers
    • 7.1.2 Technology and Innovation Drivers
    • 7.1.3 Infrastructure and Investment Drivers
    • 7.1.4 Regulatory and Policy Drivers
  • 7.2 Market Restraints
    • 7.2.1 Cost and Affordability Constraints
    • 7.2.2 Technology and Adoption Barriers
    • 7.2.3 Supply Chain and Operational Constraints
  • 7.3 Market Challenges
    • 7.3.1 Competitive Pressure and Margin Erosion
    • 7.3.2 Skills, Infrastructure and Implementation Gaps
  • 7.4 Emerging Market Opportunities
  • 7.5 Market Dynamics Impact and Time-Horizon Assessment

Chapter 8 Global Endoscopy Value Chain Analysis

  • 8.1 Industry Value Chain Overview
  • 8.2 Upstream Suppliers and Critical Inputs
  • 8.3 Technology and Component Providers
  • 8.4 Manufacturing or Service Delivery
  • 8.5 Distribution, Channel Partners and Integrators
  • 8.6 Downstream Applications and End Users
  • 8.7 Value Addition and Profit Pools
  • 8.8 Vertical Integration and Outsourcing
  • 8.9 Supplier Concentration and Risk
  • 8.10 Supply Chain Localization and Resilience

Chapter 9 Global Endoscopy Market Regulations and Policies

  • 9.1 Relevant Laws, Standards and Compliance Frameworks
  • 9.2 Product, Service, Safety and Quality Requirements
  • 9.3 Government Policies, Incentives and Subsidies
  • 9.4 Imports, Exports and Trade Barriers
  • 9.5 Public Procurement and Local Content Requirements
  • 9.6 Environmental and Sustainability Compliance
  • 9.7 Upcoming Policy Changes and Market Implications

Chapter 10 Global Endoscopy Market Hotspots and Opportunities

  • 10.1 Market Opportunity Mapping and Growth Hotspots
  • 10.2 High-Growth Applications and Customer Groups
  • 10.3 Underserved Markets and White-Space Opportunities
  • 10.4 Emerging Technology and Product Opportunities
  • 10.5 New Capacity and Investment Hotspots
  • 10.6 Market Entry and Expansion Opportunities
  • 10.7 Distribution and Partnership Opportunities
  • 10.8 Near-Term and Long-Term Commercial Potential
  • 10.9 Opportunity Attractiveness and Execution Risks

Chapter 11 Global Endoscopy Market Outlook, 2024-2032

  • 11.1 Market Size and Analysis
    • 11.1.1 Revenue (Market Measurement: 2024: USD 29,490.5 million → 2032: USD 40,359.7 million)
    • 11.1.2 Market Volume and Quantity Sold
    • 11.1.3 Historical Market Size
    • 11.1.4 Base-Year Market Size, 2024
  • 11.2 Market Forecast, 2024-2032
    • 11.2.1 Revenue Forecast to 2032
    • 11.2.2 Volume Forecast to 2032
    • 11.2.3 CAGR and Year-on-Year Growth
    • 11.2.4 Incremental Revenue Opportunity
  • 11.3 Forecast Assumptions and Scenario Analysis
    • 11.3.1 Base-Case Forecast
    • 11.3.2 Optimistic and Conservative Scenarios
    • 11.3.3 Technology, Pricing and Policy Sensitivities
  • 11.4 Market Attractiveness and Growth Outlook

Chapter 12 Global Endoscopy Market Segmentation and Outlook

  • 12.1 Segmentation Summary and Market Shares, 2024
  • 12.2 Largest and Fastest-Growing Segments
  • 12.3 By End-User - Market Size and Forecast, 2024-2032
    • 12.3.1 Segment Definition and Scope
    • 12.3.2 Historical Market Size
    • 12.3.3 Revenue Forecast, 2024-2032
    • 12.3.4 Volume Forecast, 2024-2032
    • 12.3.5 Base-Year Market Share, 2024
    • 12.3.6 Segment CAGR and Growth Drivers
    • 12.3.7 Subsegment Market Size and Forecast
      • 12.3.7.1 Hospitals
      • 12.3.7.2 Ambulatory surgical centers
    • 12.3.8 Subsegment Pricing and Adoption Trends
    • 12.3.9 Leading Suppliers and Competition
    • 12.3.10 Regional Demand and Opportunities
  • 12.4 By Application - Market Size and Forecast, 2024-2032
    • 12.4.1 Segment Definition and Scope
    • 12.4.2 Historical Market Size
    • 12.4.3 Revenue Forecast, 2024-2032
    • 12.4.4 Volume Forecast, 2024-2032
    • 12.4.5 Base-Year Market Share, 2024
    • 12.4.6 Segment CAGR and Growth Drivers
    • 12.4.7 Subsegment Market Size and Forecast
      • 12.4.7.1 Arthroscopy
      • 12.4.7.2 ENT endoscopy
      • 12.4.7.3 Pulmonary endoscopy
      • 12.4.7.4 Obstetrics/Gynecology
    • 12.4.8 Subsegment Pricing and Adoption Trends
    • 12.4.9 Leading Suppliers and Competition
    • 12.4.10 Regional Demand and Opportunities
  • 12.5 By Product Type - Market Size and Forecast, 2024-2032
    • 12.5.1 Segment Definition and Scope
    • 12.5.2 Historical Market Size
    • 12.5.3 Revenue Forecast, 2024-2032
    • 12.5.4 Volume Forecast, 2024-2032
    • 12.5.5 Base-Year Market Share, 2024
    • 12.5.6 Segment CAGR and Growth Drivers
    • 12.5.7 Subsegment Market Size and Forecast
      • 12.5.7.1 Endoscopes
      • 12.5.7.2 Visualization systems
      • 12.5.7.3 Endoscopic ultrasound
      • 12.5.7.4 Insufflator
    • 12.5.8 Subsegment Pricing and Adoption Trends
    • 12.5.9 Leading Suppliers and Competition
    • 12.5.10 Regional Demand and Opportunities
  • 12.6 Segment Growth Comparison
  • 12.7 Segment Attractiveness and Priority Matrix

Chapter 13 Global Endoscopy End-Use and Application Market Outlook

  • 13.1 End-Use Industry and Customer Demand Structure
  • 13.2 Leading Applications and Customer Groups
  • 13.3 End-Use Market Size, Share and Forecast
  • 13.4 Major End-Use Industry Deep Dives
    • 13.4.1 Customer Requirements and Use Cases
    • 13.4.2 Demand and Replacement Cycles
    • 13.4.3 Technical and Regulatory Considerations
    • 13.4.4 Purchasing and Procurement Models
    • 13.4.5 Leading Vendors and Distribution Channels
    • 13.4.6 Forecast and Commercial Opportunities
  • 13.5 Emerging Applications and Cross-Segment Demand
  • 13.6 End-Use Industry Investment Priorities

Chapter 14 Global Endoscopy Geographic Market Outlook, 2024-2032

  • 14.1 Regional Market Size and Share, 2024
  • 14.2 Regional Market Forecast, 2024-2032
  • 14.3 Regional Pricing, Production and Demand Differences
  • 14.4 North America
    • 14.4.1 United States
    • 14.4.2 Canada
    • 14.4.3 Mexico
  • 14.5 Europe
    • 14.5.1 Germany
    • 14.5.2 France
    • 14.5.3 Italy
    • 14.5.4 United Kingdom
    • 14.5.5 Spain
    • 14.5.6 Poland
    • 14.5.7 Russia
    • 14.5.8 Netherlands
    • 14.5.9 Belgium
    • 14.5.10 Sweden
    • 14.5.11 Denmark
    • 14.5.12 Norway
    • 14.5.13 Rest of Europe
  • 14.6 Asia Pacific
    • 14.6.1 China
    • 14.6.2 India
    • 14.6.3 Japan
    • 14.6.4 South Korea
    • 14.6.5 Thailand
    • 14.6.6 Indonesia
    • 14.6.7 Vietnam
    • 14.6.8 Malaysia
    • 14.6.9 Australia
    • 14.6.10 Rest of Asia Pacific
  • 14.7 Latin America
    • 14.7.1 Brazil
    • 14.7.2 Argentina
    • 14.7.3 Colombia
    • 14.7.4 Chile
    • 14.7.5 Rest of Latin America
  • 14.8 Middle East
    • 14.8.1 Saudi Arabia
    • 14.8.2 United Arab Emirates
    • 14.8.3 Turkey
    • 14.8.4 Israel
    • 14.8.5 Iran
    • 14.8.6 Rest of the Middle East
  • 14.9 Africa
    • 14.9.1 South Africa
    • 14.9.2 Egypt
    • 14.9.3 Nigeria
    • 14.9.4 Morocco
    • 14.9.5 Rest of Africa
  • 14.10 Regional Investment, Policy and Supply Chain Differences
  • 14.11 Regional Competitive Landscape
  • 14.12 Geographic Growth Hotspots

Chapter 15 Global Endoscopy Technology, Innovation and Sustainability Outlook

  • 15.1 Technology Landscape and Maturity
  • 15.2 Product, Process and Service Innovation
  • 15.3 AI, Automation and Digital Tools in the Industry
  • 15.4 Technology Adoption and Performance Benchmarking
  • 15.5 Innovation Pipeline and R&D Investment
  • 15.6 Patent and Intellectual Property Trends
  • 15.7 Energy Efficiency and Resource Management
  • 15.8 Sustainability, Recycling and Circularity
  • 15.9 Technology Roadmap, 2024-2032
  • 15.10 Risks of Obsolescence and Technology Substitution

Chapter 16 Global Endoscopy Market Key Strategic Imperatives

  • 16.1 Growth and Market Entry Priorities
  • 16.2 High-Return Products and Segments
  • 16.3 Pricing, Profitability and Cost Optimization
  • 16.4 Technology Investment and Product Differentiation
  • 16.5 Supply Chain Localization and Resilience
  • 16.6 Distribution and Customer Acquisition
  • 16.7 Partnership, Acquisition and Capacity Strategy
  • 16.8 Regional Expansion Priorities
  • 16.9 Short-, Medium- and Long-Term Actions

Chapter 17 Competition Outlook

  • 17.1 Industry Competition Characteristics
  • 17.2 Market Structure and Concentration
  • 17.3 Market Share and Competitive Positioning, 2024
  • 17.4 Company-Wise Revenue and Product Benchmarking
  • 17.5 Production and Service Capacity Benchmarking
  • 17.6 Technology, Pricing and Differentiation
  • 17.7 Regional Footprint and Distribution Strength
  • 17.8 Mergers, Acquisitions and Strategic Alliances
  • 17.9 New Entrants and Competitive Threats
  • 17.10 Porter's Five Forces and Industry Attractiveness
  • 17.11 Competitive Outlook, 2024-2032

Chapter 18 Company Profiles

  • 18.1 Company Coverage and Selection Criteria
  • 18.2 Olympus
    • 18.2.1 Business Description
    • 18.2.2 Company Ownership and Geographic Presence
    • 18.2.3 Product and Service Portfolio
    • 18.2.4 Manufacturing and Operating Footprint
    • 18.2.5 Production Capacity and Expansion Plans
    • 18.2.6 Financial Performance and Investment
    • 18.2.7 Market Share and Competitive Position
    • 18.2.8 Technology and Innovation Capabilities
    • 18.2.9 Strategic Alliances or Partnerships
    • 18.2.10 Recent Developments
    • 18.2.11 Growth Strategy and Outlook
  • 18.3 KARL STORZ
  • 18.4 Johnson & Johnson
  • 18.5 Boston Scientific
  • 18.6 Medtronic
  • 18.7 FUJIFILM
  • 18.8 Smith & Nephew
  • 18.9 Stryker
  • 18.10 CONMED
  • 18.11 Ambu
  • 18.12 Other Relevant Market Participants

Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.

Chapter 19 Disclaimer

  • 19.1 Research and Forecast Disclaimer
  • 19.2 Data Source and Estimation Limitations

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.

Methodology

Meet the Team

Dr. Pankaj Sharma
Dr. Pankaj Sharma

Healthcare Domain Expert & Medical Advisor

Dr. Pankaj Sharma is an anesthesiologist and healthcare strategic advisor who reviews epidemiological models, therapeutic market assessments and clinical assumptions at Credence Research Inc, so that quantitative forecasts reflect clinical realities.

Deepti Agrawal

Reviewed by

Deepti Agrawal

Head of Editorial Operations

Related Topics

Australia Group 2 Powered Mobility Devices Market Size, Share, Growth and Forecast, 2025-2035

Australia Group 2 powered mobility devices market rises from USD 35.8 million in 2025 to USD 84.1 million by 2035, led by NDIS demand and new aged-care funding.

Australia Blood Group Typing Market Size, Share, Growth and Forecast, 2025-2035

Australia blood group typing market worth USD 55.3 million in 2025 will reach USD 88.5 million by 2035 at a 4.81% CAGR on transfusion and antenatal testing.

Australia Extracorporeal Shock Wave Lithotripsy Market Size, Share, Growth and Forecast, 2025-2035

Australia extracorporeal shock wave lithotripsy market worth USD 11.5 million in 2025 is set to reach USD 12.3 million by 2035 at a 0.63% CAGR.

Australia Dual-Energy X-Ray Absorptiometry Market Size, Share, Growth and Forecast, 2025-2035

Australia dual-energy X-ray absorptiometry market worth USD 12.2 million in 2025 will reach USD 22.5 million by 2035 at a 6.28% CAGR as bone testing grows.

Australia Dental Imaging Market Size, Share, Growth and Forecast, 2025-2035

Australia dental imaging market worth USD 69.0 million in 2025 will reach USD 160.0 million by 2035 at an 8.78% CAGR as clinics adopt 3D scans and software.

Australia Needle-Free Injectors Market Size, Share, Growth and Forecast, 2025-2035

Australia needle-free injectors market worth USD 60.5 million in 2025 will reach USD 144.8 million by 2035 at a 9.13% CAGR on diabetes and home care demand.